42312 Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 / Notices 

Dated: August 13, 2009. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–20152 Filed 8–20–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Meeting; Moving Into the 

Future—New Dimensions and 

Strategies for Women’s Health 

Research for the National Institutes of 

Health 

Notice is hereby given that the Office 

of Research on Women’s Health 

(ORWH), Office of the Director, National 

Institutes of Health, Department of 

Health and Human Services, in 

collaboration with Northwestern 

University’s Feinberg School of 

Medicine and Northwestern Memorial 

Hospital, will convene a public hearing 

and scientific workshop on October 14– 

16, 2009, at Northwestern University, 

Thorne Auditorium, Arthur Rubloff 

Building, Chicago, Illinois. 

Purpose of the Meeting 

With rapid advances in science and 

wider global understanding of women’s 

health and sex/gender contributions to 

well-being and disease, the purpose of 

the meeting is to ensure that NIH 

continues to support cutting-edge 

women’s health research that is based 

upon the most advanced techniques and 

methodologies. The meeting format is 

designed to promote an interactive 

discussion involving leading scientists, 

advocacy groups, public policy experts, 

health care providers, and the general 

public. The Chicago meeting is the 

fourth in a series that will be convened 

throughout the Nation to help the 

ORWH and NIH move into the next 

decade of women’s health research. 

As science and technology advance 

and fields such as computational 

biology demonstrate the power of 

interdisciplinary research, it remains 

critical for sex and gender factors to be 

integrated into broad experimental 

methodologies and scientific 

approaches across the lifespan. 

Biomedical and behavioral research are 

also necessary to understand how 

cultural, ethnic, and racial differences 

influence the causes, diagnosis, 

progression, treatment, and outcome of 

disease among different populations, 

including women of diverse geographic 

locations and socioeconomic 

backgrounds. Furthermore, the fact that 

there are health differences among 

diverse populations of women remains 

a critical area in need of continued 

focus and attention. 

The ORWH challenges all meeting 

attendees to assist the NIH in defining 

the women’s health research agenda of 

the future by thinking beyond 

traditional women’s health issues. The 

ORWH and NIH ask meeting 

participants to consider creative 

strategies to identify areas of research 

that are best poised for advancement, 

identify innovative ways in which 

persistent issues of health and disease 

can be addressed, and explore new 

horizons of scientific concepts and 

investigative approaches. Attention also 

needs to be paid to new areas of science 

application, new technologies, and 

continuing basic science investigations. 

Clinical questions that are not currently 

the focus of research priorities need to 

be considered to ensure that women’s 

health research is optimally served and 

that the ORWH can continue to provide 

leadership for the benefit of women’s 

health, nationally and internationally. 

Meeting Format 

The meeting will consist of public 

testimony, scientific panels and seven 

concurrent scientific working groups. 

Specifically, on October 14, individuals 

representing a full spectrum of 

organizations interested in biomedical 

and behavioral research on women’s 

health issues will have an opportunity 

to provide public testimony from 2 to 6 

p.m. On October 15 and 16, plenary 

sessions will focus on the intersection of 

health care, public policy, and 

biomedical research; on emerging issues 

and trends in health care; and on 

research paradigms of the future. The 

seven concurrent afternoon sessions on 

October 15 will focus on a range of 

research areas, including preventive 

heath and special populations; clinical 

trials/research; new technologies, 

bioengineering, imaging; genetics/ 

epigenetics; sex hormones and disease; 

neuroscience; and women in science 

careers. On October 16, the morning 

session will be devoted to reports by the 

working group co-chairs regarding the 

recommendations emerging from 

working group deliberations on the 

previous day. The meeting will adjourn 

at 12:45 p.m. on October 16. 

Public Testimony 

The ORWH invites individuals with 

an interest in research related to 

women’s health to provide written and/ 

or oral testimony on these topics and/ 

or on issues related to the sustained 

advancement of women in various 

biomedical careers. Due to time 

constraints, only one representative 

from an organization or professional 

specialty group may give oral testimony. 

Individuals not representing an 

organized entity but a personal point of 

view are similarly invited to present 

written and/or oral testimony. A letter 

of intent to present oral testimony is 

necessary and should be sent 

electronically to http:// 

www.orwhmeetings.com/ 

movingintothefuture/ or by mail to Ms. 

Jory Barone, Educational Services, Inc., 

4350 East-West Highway, Suite 1100, 

Bethesda, MD 20814, no later than 

October 4, 2009. The date of receipt of 

the communication will establish the 

order of those selected to give oral 

testimony at the October meeting. 

Those wishing to present oral 

testimony are also asked to submit a 

written form of their testimony that is 

limited to a maximum of 10 pages, 

double spaced, 12 point font, and 

should include a brief description of the 

organization. Electronic submission to 

the above Web site is preferred; 

however, for those who do not have 

access to electronic means, written 

testimony, bound by the restrictions 

previously noted and postmarked no 

later than October 4, 2009, can be 

mailed to Ms. Jory Barone at the above 

address. All written presentations must 

meet the established page limitations. 

Submissions exceeding this limit will 

not be accepted and will be returned. 

Oral testimony of this material at the 

meeting will be limited to no more than 

5–6 minutes in length. 

Because of time constraints for oral 

testimony, testifiers may not be able to 

present the complete information as it is 

contained in their written form 

submitted for inclusion in the public 

record for the meeting. Therefore, 

testifiers are requested to summarize the 

major points of emphasis from the 

written testimony, not to exceed 6 

minutes of oral testimony. Those 

individuals or organizations that have 

indicated they will present oral 

testimony at the meeting in Chicago will 

be notified prior to the meeting 

regarding the approximate time for their 

oral presentation. 

Individuals and organizations wishing 

to provide written statements only 

should send a copy of their statements, 

electronically or by mail, to the above 

Web site or address by October 4, 2009. 

Written testimony received by that date 

will be made available at the October 

14–16 meeting. Logistics questions 

related to the meeting should be 

addressed to Ms. Jory Barone at ESI, 

while program-specific questions 

should be addressed to Dr. Jody K. 

Hirsch at the Feinberg School of 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 / Notices 42313 

Medicine, Chicago, Illinois, at telephone 

number 312–503–3659 or e-mail address 

jkhirsch@northwestern.edu. 

At the conclusion of the regional 

meetings, the ORWH will hold a 

meeting at the NIH to summarize the 

deliberations from the regional 

conferences. The resulting report to the 

ORWH and the NIH will ensure that 

women’s health research in the coming 

decade continues to support a vigorous 

research agenda incorporating the latest 

advances in technology and cuttingedge science. 

Dated: August 13, 2009. 

Raynard S. Kington, 

Acting Director, National Institutes of Health. 

[FR Doc. E9–20149 Filed 8–20–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Cancer Institute Director’s 

Consumer Liaison Group. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: National Cancer 

Institute Director’s Consumer Liaison Group. 

Date: October 20–22, 2009. 

Time: October 20, 2009, 2 p.m. to 6 p.m. 

Agenda: Welcome, Overview of the NCI 

Advanced Therapeutics Platform, Expert 

Panel on NCI Therapeutics Platform. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892. 

Time: October 21, 2009, 8:30 a.m. to 5:30 

p.m. 

Agenda: Gaining Community Input on NCI 

Therapeutics Platform, Communicating with 

the Community About the NCI Therapeutics 

Platform, Advocates in Research Working 

Group Discussion, NCI National Outreach 

Network Discussion. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892. 

Time: October 22, 2009, 8:30 a.m. to 1 p.m. 

Agenda: Communicating with the 

Community about the NCI Therapeutics 

Platform (cont’d), Engaging the Community 

Around the NCI Therapeutics Platform, 

Discussion with NCI Director. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892. 

Contact Person: Benjamin Carollo, MPA, 

Advocacy Relations Manager, Office of 

Advocacy Relations, Building 31, Room 

10A30, 31 Center Drive, MSC 2580, National 

Cancer Institute, NIH, DHHS, Bethesda, MD 

20892–2580. 301–496–0307. 

carollob@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page:http:// 

deainfo.nci.nih.gov/advisory/dclg/dclg.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: August 17, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–20170 Filed 8–20–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Advisory Environmental 

Health Sciences Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Environmental Health Sciences Council. 

Date: September 15–16, 2009. 

Open: September 15, 2009, 8:30 a.m. to 5 

p.m. 

Agenda: Discussion of program policies 

and issues. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T. W. Alexander Drive, Research 

Triangle Park, NC 27709. 

Open: September 16, 2009, 8:30 a.m. to 

10:30 a.m. 

Agenda: Discussion of program policies 

and issues. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T. W. Alexander Drive, Research 

Triangle Park, NC 27709. 

Closed: September 16, 2009, 10:30 a.m. to 

12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T. W. Alexander Drive, Research 

Triangle Park, NC 27709. 

Contact Person: Gwen W Collman, PHD, 

Interim Director, Division of Extramural 

Research & Training, National Institutes of 

Health, Nat. Inst. of Environmental Health 

Sciences, 615 Davis Dr., KEY615/3112, 

Research Triangle Park, NC 27709, (919) 541– 

4980, collman@niehs.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.niehs.nih.gov/dert/c-agenda.htm, where 

an agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation—Health Risks from 

Environmental Exposures; 93.142, NIEHS 

Hazardous Waste Worker Health and Safety 

Training; 93.143, NIEHS Superfund 

Hazardous Substances—Basic Research and 

Education; 93.894, Resources and Manpower 

Development in the Environmental Health 

Sciences; 93.113, Biological Response to 

Environmental Health Hazards; 93.114, 

Applied Toxicological Research and Testing, 

National Institutes of Health, HHS) 


srobinson on DSKHWCL6B1PROD with NOTICES